id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
sequence | ner_tags
sequence |
---|---|---|---|---|---|
NCT02132598 | ,69:78:treatment | Any of the following within 6 months before the first dose of study treatment | 1 | [
"Any",
"of",
"the",
"following",
"within",
"6",
"months",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01896921 | 1:15:treatment,25:33:treatment,35:48:treatment,50:63:treatment,68:77:treatment | CYP3A inducers (such as rifampin, carbamazepine, phenobarbital and phenytoin) | 1 | [
"CYP3A",
"inducers",
"(",
"such",
"as",
"rifampin",
",",
"carbamazepine",
",",
"phenobarbital",
"and",
"phenytoin",
")"
] | [
1,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0
] |
NCT02013492 | 25:35:chronic_disease | Patients with worsening depression that has not been addressed clinically | 1 | [
"Patients",
"with",
"worsening",
"depression",
"that",
"has",
"not",
"been",
"addressed",
"clinically"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02303977 | ,41:53:treatment | Pregnant or breast-feeding patients, as chemotherapy is thought to present substantial risk to the fetus/infant | 1 | [
"Pregnant",
"or",
"breast-feeding",
"patients",
",",
"as",
"chemotherapy",
"is",
"thought",
"to",
"present",
"substantial",
"risk",
"to",
"the",
"fetus/infant"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02561104 | 13:27:treatment | presence of cornea implant | 1 | [
"presence",
"of",
"cornea",
"implant"
] | [
0,
0,
1,
1
] |
NCT02367040 | ,89:98:treatment | Adequate baseline laboratory values collected no more than 7 days before starting study treatment | 1 | [
"Adequate",
"baseline",
"laboratory",
"values",
"collected",
"no",
"more",
"than",
"7",
"days",
"before",
"starting",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02555280 | 14:22:chronic_disease | Uncontrolled diabetes | 1 | [
"Uncontrolled",
"diabetes"
] | [
0,
2
] |
NCT02165007 | 14:37:chronic_disease | Patient with active Hepatitis B or C determined by serology and/or NAAT | 1 | [
"Patient",
"with",
"active",
"Hepatitis",
"B",
"or",
"C",
"determined",
"by",
"serology",
"and/or",
"NAAT"
] | [
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT01639508 | 1:18:treatment,23:27:cancer,31:47:cancer,,74:100:treatment,,145:182:treatment,,259:282:treatment | Radiation therapy for bone or brain metastasis within 2 weeks, any other external radiation therapy within 4 weeks of first dose of study drug. Systemic treatment with radionuclides within 4weeks. Subjects with clinically relevant ongoing complications from prior radiation therapy are not eligible | 1 | [
"Radiation",
"therapy",
"for",
"bone",
"or",
"brain",
"metastasis",
"within",
"2",
"weeks",
",",
"any",
"other",
"external",
"radiation",
"therapy",
"within",
"4",
"weeks",
"of",
"first",
"dose",
"of",
"study",
"drug",
".",
"Systemic",
"treatment",
"with",
"radionuclides",
"within",
"4weeks",
".",
"Subjects",
"with",
"clinically",
"relevant",
"ongoing",
"complications",
"from",
"prior",
"radiation",
"therapy",
"are",
"not",
"eligible"
] | [
1,
1,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0
] |
NCT01600040 | 24:34:cancer, | History of a different malignancy except if disease-free for at least 5 years and are deemed by the investigator ro be at low risk for recurrence of that malignancy | 1 | [
"History",
"of",
"a",
"different",
"malignancy",
"except",
"if",
"disease-free",
"for",
"at",
"least",
"5",
"years",
"and",
"are",
"deemed",
"by",
"the",
"investigator",
"ro",
"be",
"at",
"low",
"risk",
"for",
"recurrence",
"of",
"that",
"malignancy"
] | [
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02132598 | 32:43:chronic_disease | Any history of congenital long QT syndrome | 1 | [
"Any",
"history",
"of",
"congenital",
"long",
"QT",
"syndrome"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT01532687 | 5:35:treatment,,84:152:treatment,158:167:treatment,169:178:treatment,184:195:treatment | Any prior treatment with pazopanib or vascular endothelial growth factor (VEGF) or vascular endothelial growth factor receptor (VEGFR)-targeting agents (eg. sorafenib, sunitinib, and bevacizumab) | 1 | [
"Any",
"prior",
"treatment",
"with",
"pazopanib",
"or",
"vascular",
"endothelial",
"growth",
"factor",
"(",
"VEGF",
")",
"or",
"vascular",
"endothelial",
"growth",
"factor",
"receptor",
"(",
"VEGFR",
")",
"-targeting",
"agents",
"(",
"eg",
".",
"sorafenib",
",",
"sunitinib",
",",
"and",
"bevacizumab",
")"
] | [
0,
1,
1,
1,
1,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
0
] |
NCT02405078 | 24:31:treatment,46:66:treatment,71:109:treatment | Suitable candidate for therapy with standard salvage chemotherapy and autologous stem cell transplant (ASCT) as determined by the treating physician | 1 | [
"Suitable",
"candidate",
"for",
"therapy",
"with",
"standard",
"salvage",
"chemotherapy",
"and",
"autologous",
"stem",
"cell",
"transplant",
"(",
"ASCT",
")",
"as",
"determined",
"by",
"the",
"treating",
"physician"
] | [
0,
0,
0,
1,
0,
0,
1,
1,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02100891 | 1:4:chronic_disease | HIV seropositive patients | 1 | [
"HIV",
"seropositive",
"patients"
] | [
2,
0,
0
] |
NCT02682407 | 8:18:cancer | Have a malignancy | 1 | [
"Have",
"a",
"malignancy"
] | [
0,
0,
3
] |
NCT02101034 | ,,,187:196:treatment | Female patients must be surgically sterile or be postmenopausal, or must agree to use effective contraceptive during the period of the trial and for at least 90 days after completion of treatment | 1 | [
"Female",
"patients",
"must",
"be",
"surgically",
"sterile",
"or",
"be",
"postmenopausal",
",",
"or",
"must",
"agree",
"to",
"use",
"effective",
"contraceptive",
"during",
"the",
"period",
"of",
"the",
"trial",
"and",
"for",
"at",
"least",
"90",
"days",
"after",
"completion",
"of",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01715220 | 15:54:chronic_disease,67:78:chronic_disease,,136:141:chronic_disease,162:172:chronic_disease,174:204:chronic_disease,248:269:chronic_disease,271:288:chronic_disease,349:377:treatment,,417:430:allergy_name | Patients with obstructive hypertrophic cardiomyopathy, pronounced hypovolemia, alcohol use in the last 8 hours, clinical intoxication, STEMI or presumed cardiac chest pain, inferior myocardial infarction with right ventricular involvement, raised intracranial pressure, cardiac tamponade and patients taking certain drugs for erectile dysfunction (phosphodiesterase inhibitors), pregnancy or with a known allergy to nitroglycerin will be excluded from the study | 1 | [
"Patients",
"with",
"obstructive",
"hypertrophic",
"cardiomyopathy",
",",
"pronounced",
"hypovolemia",
",",
"alcohol",
"use",
"in",
"the",
"last",
"8",
"hours",
",",
"clinical",
"intoxication",
",",
"STEMI",
"or",
"presumed",
"cardiac",
"chest",
"pain",
",",
"inferior",
"myocardial",
"infarction",
"with",
"right",
"ventricular",
"involvement",
",",
"raised",
"intracranial",
"pressure",
",",
"cardiac",
"tamponade",
"and",
"patients",
"taking",
"certain",
"drugs",
"for",
"erectile",
"dysfunction",
"(",
"phosphodiesterase",
"inhibitors",
")",
",",
"pregnancy",
"or",
"with",
"a",
"known",
"allergy",
"to",
"nitroglycerin",
"will",
"be",
"excluded",
"from",
"the",
"study"
] | [
0,
0,
2,
2,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0
] |
NCT01631617 | 33:60:allergy_name | Known allergy or sensitivity to sodium hypochlorite (NaOCl) | 1 | [
"Known",
"allergy",
"or",
"sensitivity",
"to",
"sodium",
"hypochlorite",
"(",
"NaOCl",
")"
] | [
0,
0,
0,
0,
0,
4,
4,
4,
0,
0
] |
NCT02508038 | 19:39:treatment | Enrollment in any other clinical study from screening up to Day 100 | 1 | [
"Enrollment",
"in",
"any",
"other",
"clinical",
"study",
"from",
"screening",
"up",
"to",
"Day",
"100"
] | [
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01802346 | 1:14:cancer,52:64:treatment,88:116:treatment, | Breast cancer subjects may not have received prior chemotherapy, with the exception of curative-intent chemotherapy for a separate malignancy more than 3 years ago | 1 | [
"Breast",
"cancer",
"subjects",
"may",
"not",
"have",
"received",
"prior",
"chemotherapy",
",",
"with",
"the",
"exception",
"of",
"curative-intent",
"chemotherapy",
"for",
"a",
"separate",
"malignancy",
"more",
"than",
"3",
"years",
"ago"
] | [
3,
3,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03067571 | ,,87:96:treatment,, | A man who is sexually active with a woman of childbearing potential and has not had a vasectomy must agree to use a barrier method of birth control eg, either condom with spermicidal foam/gel/film/cream/suppository or partner with occlusive cap (diaphragm or cervical/vault caps) with spermicidal foam/gel/film/cream/suppository, and all men must also not donate sperm during the study and for 3 months after receiving the last dose of study drug | 1 | [
"A",
"man",
"who",
"is",
"sexually",
"active",
"with",
"a",
"woman",
"of",
"childbearing",
"potential",
"and",
"has",
"not",
"had",
"a",
"vasectomy",
"must",
"agree",
"to",
"use",
"a",
"barrier",
"method",
"of",
"birth",
"control",
"eg",
",",
"either",
"condom",
"with",
"spermicidal",
"foam/gel/film/cream/suppository",
"or",
"partner",
"with",
"occlusive",
"cap",
"(",
"diaphragm",
"or",
"cervical/vault",
"caps",
")",
"with",
"spermicidal",
"foam/gel/film/cream/suppository",
",",
"and",
"all",
"men",
"must",
"also",
"not",
"donate",
"sperm",
"during",
"the",
"study",
"and",
"for",
"3",
"months",
"after",
"receiving",
"the",
"last",
"dose",
"of",
"study",
"drug"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02519322 | 1:17:cancer,19:41:cancer,45:60:cancer | Brain metastases, leptomeningeal disease or bone metastases | 1 | [
"Brain",
"metastases",
",",
"leptomeningeal",
"disease",
"or",
"bone",
"metastases"
] | [
3,
3,
0,
3,
3,
0,
3,
3
] |
NCT02923544 | 43:55:treatment | Participant must be scheduled for a total laparoscopic | 1 | [
"Participant",
"must",
"be",
"scheduled",
"for",
"a",
"total",
"laparoscopic"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02439450 | 28:46:chronic_disease | Active, known or suspected autoimmune disease | 1 | [
"Active",
",",
"known",
"or",
"suspected",
"autoimmune",
"disease"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT02686528 | 31:53:treatment | Patients undergoing a primary total hip arthroplasty via the posterior approach by participating attending surgeons at this institution | 1 | [
"Patients",
"undergoing",
"a",
"primary",
"total",
"hip",
"arthroplasty",
"via",
"the",
"posterior",
"approach",
"by",
"participating",
"attending",
"surgeons",
"at",
"this",
"institution"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02952534 | 1:16:treatment,26:40:treatment,42:54:treatment,56:72:treatment,80:107:treatment | Prior treatment with any PARP inhibitor, mitoxantrone, cyclophosphamide or any platinum-based chemotherapy | 1 | [
"Prior",
"treatment",
"with",
"any",
"PARP",
"inhibitor",
",",
"mitoxantrone",
",",
"cyclophosphamide",
"or",
"any",
"platinum-based",
"chemotherapy"
] | [
1,
1,
0,
0,
1,
1,
0,
1,
0,
1,
0,
0,
1,
1
] |
NCT02611063 | 23:47:cancer | Complete remission of hematological malignancy prior to transplantation | 1 | [
"Complete",
"remission",
"of",
"hematological",
"malignancy",
"prior",
"to",
"transplantation"
] | [
0,
0,
0,
3,
3,
0,
0,
0
] |
NCT01851694 | 1:25:chronic_disease | Pancreatic insufficiency | 1 | [
"Pancreatic",
"insufficiency"
] | [
2,
2
] |
NCT02433210 | 28:43:allergy_name | Problem with or allergy to anticoagulation | 1 | [
"Problem",
"with",
"or",
"allergy",
"to",
"anticoagulation"
] | [
0,
0,
0,
0,
0,
4
] |
NCT03113825 | 7:24:treatment | Prior radiation therapy to the chest [Period 2] | 1 | [
"Prior",
"radiation",
"therapy",
"to",
"the",
"chest",
"[",
"Period",
"2",
"]"
] | [
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02560766 | 13:36:treatment, | Received an investigational product within 6 months prior to dosing | 1 | [
"Received",
"an",
"investigational",
"product",
"within",
"6",
"months",
"prior",
"to",
"dosing"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01697371 | 34:46:treatment | Tense ascites requiring frequent paracentesis | 1 | [
"Tense",
"ascites",
"requiring",
"frequent",
"paracentesis"
] | [
0,
0,
0,
0,
1
] |
NCT02153229 | 22:38:cancer,51:54:cancer,80:89:treatment,98:126:cancer,128:147:cancer,151:166:cancer,184:199:cancer | Patients with active invasive cancers, other than MPM, that require additional treatment, except non-melanomatous skin cancer, superficial bladder or cervical cancer, and early-stage prostate cancer | 1 | [
"Patients",
"with",
"active",
"invasive",
"cancers",
",",
"other",
"than",
"MPM",
",",
"that",
"require",
"additional",
"treatment",
",",
"except",
"non-melanomatous",
"skin",
"cancer",
",",
"superficial",
"bladder",
"or",
"cervical",
"cancer",
",",
"and",
"early-stage",
"prostate",
"cancer"
] | [
0,
0,
0,
3,
3,
0,
0,
0,
3,
0,
0,
0,
0,
1,
0,
0,
3,
3,
3,
0,
3,
3,
0,
3,
3,
0,
0,
0,
3,
3
] |
NCT02143726 | 1:19:treatment, | Prior chemotherapy is allowed if ≥ 28 days prior to registration on this protocol | 1 | [
"Prior",
"chemotherapy",
"is",
"allowed",
"if",
"≥",
"28",
"days",
"prior",
"to",
"registration",
"on",
"this",
"protocol"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02588027 | 28:53:treatment | Patients with a history of prior rotator cuff repair | 1 | [
"Patients",
"with",
"a",
"history",
"of",
"prior",
"rotator",
"cuff",
"repair"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02946892 | 1:26:chronic_disease | nondilated cardiomyopathy | 1 | [
"nondilated",
"cardiomyopathy"
] | [
2,
2
] |
NCT02069925 | ,25:40:chronic_disease | Within first 3 years of psychosis onset (per pre-defined SOS threshold criteria) | 1 | [
"Within",
"first",
"3",
"years",
"of",
"psychosis",
"onset",
"(",
"per",
"pre-defined",
"SOS",
"threshold",
"criteria",
")"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02323880 | 22:44:chronic_disease | Patients who have an uncontrolled infection | 1 | [
"Patients",
"who",
"have",
"an",
"uncontrolled",
"infection"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02252081 | 16:26:cancer,30:36:cancer,,77:118:cancer | Current active malignancy or cancer history in the prior 5 years (excluding squamous cell and basal cell skin cancers) | 1 | [
"Current",
"active",
"malignancy",
"or",
"cancer",
"history",
"in",
"the",
"prior",
"5",
"years",
"(",
"excluding",
"squamous",
"cell",
"and",
"basal",
"cell",
"skin",
"cancers",
")"
] | [
0,
0,
3,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
3,
0
] |
NCT01804465 | 21:31:cancer | Concurrent or prior malignancy | 1 | [
"Concurrent",
"or",
"prior",
"malignancy"
] | [
0,
0,
0,
3
] |
NCT02298790 | 1:19:chronic_disease | Hearing impairment | 1 | [
"Hearing",
"impairment"
] | [
2,
2
] |
NCT02124772 | 20:30:cancer | History of another malignancy including resected non-melanomatous skin cancer | 1 | [
"History",
"of",
"another",
"malignancy",
"including",
"resected",
"non-melanomatous",
"skin",
"cancer"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT02139280 | 1:16:treatment,21:52:treatment,45:52:treatment, | Prior Treatment: No previous cytotoxic chemotherapy within 4 weeks prior to initiation of therapy | 1 | [
"Prior",
"Treatment",
":",
"No",
"previous",
"cytotoxic",
"chemotherapy",
"within",
"4",
"weeks",
"prior",
"to",
"initiation",
"of",
"therapy"
] | [
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02908906 | 1:37:chronic_disease | psychiatric illness/social situation that would limited compliance with study requirements | 1 | [
"psychiatric",
"illness/social",
"situation",
"that",
"would",
"limited",
"compliance",
"with",
"study",
"requirements"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02128906 | 1:4:chronic_disease | HIV testing is not required for entry into this protocol | 1 | [
"HIV",
"testing",
"is",
"not",
"required",
"for",
"entry",
"into",
"this",
"protocol"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02068092 | 183:196:cancer | A known deleterious mutation in BRCA1, BRCA2, PTEN, or TP53. (Note: The participant must be a documented carrier to meet this criterion. If there is a known mutation in a hereditary breast cancer susceptibility gene in a participant's family member, the participant herself must have undergone genetic testing as per National Comprehensive Cancer Network guidelines to be eligible per this criterion.) | 1 | [
"A",
"known",
"deleterious",
"mutation",
"in",
"BRCA1",
",",
"BRCA2",
",",
"PTEN",
",",
"or",
"TP53",
".",
"(",
"Note",
":",
"The",
"participant",
"must",
"be",
"a",
"documented",
"carrier",
"to",
"meet",
"this",
"criterion",
".",
"If",
"there",
"is",
"a",
"known",
"mutation",
"in",
"a",
"hereditary",
"breast",
"cancer",
"susceptibility",
"gene",
"in",
"a",
"participant",
"'s",
"family",
"member",
",",
"the",
"participant",
"herself",
"must",
"have",
"undergone",
"genetic",
"testing",
"as",
"per",
"National",
"Comprehensive",
"Cancer",
"Network",
"guidelines",
"to",
"be",
"eligible",
"per",
"this",
"criterion",
".",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02452203 | 18:29:treatment,74:92:treatment,100:115:treatment,117:124:treatment,126:165:treatment,167:184:treatment,186:198:treatment,200:204:treatment,206:209:treatment,211:221:treatment,223:229:treatment,231:244:treatment,246:254:treatment | Certain drugs or medications consumed within the past week including any psychoactive drugs (e.g., benzodiazepines, opiates, selective serotonin reuptake inhibitors, dopamine agonists, barbiturates, MDMA, LSD, psilocybin, peyote, phencyclidine, ketamine) | 1 | [
"Certain",
"drugs",
"or",
"medications",
"consumed",
"within",
"the",
"past",
"week",
"including",
"any",
"psychoactive",
"drugs",
"(",
"e.g.",
",",
"benzodiazepines",
",",
"opiates",
",",
"selective",
"serotonin",
"reuptake",
"inhibitors",
",",
"dopamine",
"agonists",
",",
"barbiturates",
",",
"MDMA",
",",
"LSD",
",",
"psilocybin",
",",
"peyote",
",",
"phencyclidine",
",",
"ketamine",
")"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
1,
0,
1,
1,
1,
1,
0,
1,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0
] |
NCT02634957 | 1:30:cancer | SCC (squamous cell carcinoma) | 1 | [
"SCC",
"(",
"squamous",
"cell",
"carcinoma",
")"
] | [
3,
3,
3,
3,
0,
0
] |
NCT02404155 | 1:16:chronic_disease | viral infection | 1 | [
"viral",
"infection"
] | [
2,
2
] |
NCT02203695 | 35:58:chronic_disease | History of clinically significant ventricular arrhythmias | 1 | [
"History",
"of",
"clinically",
"significant",
"ventricular",
"arrhythmias"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02816736 | 62:70:allergy_name,76:80:allergy_name,84:87:allergy_name,147:168:chronic_disease | History of hypersensitivity or intolerance (unmodifiable) to Entresto™, an ACEI or ARB as well as known or suspected contraindications (including hereditary angioedema) to the study drugs | 1 | [
"History",
"of",
"hypersensitivity",
"or",
"intolerance",
"(",
"unmodifiable",
")",
"to",
"Entresto™",
",",
"an",
"ACEI",
"or",
"ARB",
"as",
"well",
"as",
"known",
"or",
"suspected",
"contraindications",
"(",
"including",
"hereditary",
"angioedema",
")",
"to",
"the",
"study",
"drugs"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
4,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02438371 | 1:26:treatment, | prior tocolytic treatment during their pregnancy | 1 | [
"prior",
"tocolytic",
"treatment",
"during",
"their",
"pregnancy"
] | [
1,
1,
1,
0,
0,
0
] |
NCT02567422 | 13:37:chronic_disease, | Symptomatic congestive heart failure (requiring hospital stay within the last 6 months) | 1 | [
"Symptomatic",
"congestive",
"heart",
"failure",
"(",
"requiring",
"hospital",
"stay",
"within",
"the",
"last",
"6",
"months",
")"
] | [
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03157167 | 16:19:chronic_disease | The subject is HIV positive | 1 | [
"The",
"subject",
"is",
"HIV",
"positive"
] | [
0,
0,
0,
2,
0
] |
NCT02631850 | 11:24:treatment, | Receiving Botox therapy currently or in the past 3 months | 1 | [
"Receiving",
"Botox",
"therapy",
"currently",
"or",
"in",
"the",
"past",
"3",
"months"
] | [
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02388685 | 1:23:chronic_disease | Critical limb ischemia | 1 | [
"Critical",
"limb",
"ischemia"
] | [
2,
2,
2
] |
NCT02040610 | 51:75:cancer, | Pathological (histologically) proven diagnosis of prostatic adenocarcinoma within 365 days (1 year) | 1 | [
"Pathological",
"(",
"histologically",
")",
"proven",
"diagnosis",
"of",
"prostatic",
"adenocarcinoma",
"within",
"365",
"days",
"(",
"1",
"year",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT03102580 | 1:23:chronic_disease | Inflammatory arthritis | 1 | [
"Inflammatory",
"arthritis"
] | [
2,
2
] |
NCT02541955 | 20:67:treatment | Stable concomitant Disease Modifying Anti-Rheumatic Drugs (DMARDs) | 1 | [
"Stable",
"concomitant",
"Disease",
"Modifying",
"Anti-Rheumatic",
"Drugs",
"(",
"DMARDs",
")"
] | [
0,
0,
1,
1,
1,
1,
1,
0,
0
] |
NCT02513797 | 8:20:chronic_disease | Active endocarditis | 1 | [
"Active",
"endocarditis"
] | [
0,
2
] |
NCT02125786 | ,,67:84:treatment | Pregnant women are excluded from enrollment on this study because radiation therapy is an agent with the potential for teratogenic or abortifacient effects | 1 | [
"Pregnant",
"women",
"are",
"excluded",
"from",
"enrollment",
"on",
"this",
"study",
"because",
"radiation",
"therapy",
"is",
"an",
"agent",
"with",
"the",
"potential",
"for",
"teratogenic",
"or",
"abortifacient",
"effects"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02278250 | 59:69:cancer,113:145:cancer,208:227:cancer,264:280:treatment,285:303:cancer, | Participants with advanced (locally advanced incurable or metastatic) histologically or cytologically confirmed high-grade serous ovarian cancer (high nuclear Grades 2 or 3). Participants should have either platinum-refractory (disease progression during initial platinum therapy) or platinum-resistant (disease progression <6 months after completion of platinum therapy) disease | 1 | [
"Participants",
"with",
"advanced",
"(",
"locally",
"advanced",
"incurable",
"or",
"metastatic",
")",
"histologically",
"or",
"cytologically",
"confirmed",
"high-grade",
"serous",
"ovarian",
"cancer",
"(",
"high",
"nuclear",
"Grades",
"2",
"or",
"3",
")",
".",
"Participants",
"should",
"have",
"either",
"platinum-refractory",
"(",
"disease",
"progression",
"during",
"initial",
"platinum",
"therapy",
")",
"or",
"platinum-resistant",
"(",
"disease",
"progression",
"<",
"6",
"months",
"after",
"completion",
"of",
"platinum",
"therapy",
")",
"disease"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01787409 | 30:55:treatment | Capable of swallowing intact study medication capsules | 1 | [
"Capable",
"of",
"swallowing",
"intact",
"study",
"medication",
"capsules"
] | [
0,
0,
0,
0,
1,
1,
1
] |
NCT02053363 | 12:38:chronic_disease | History of deep vein thrombosis (DVT) | 1 | [
"History",
"of",
"deep",
"vein",
"thrombosis",
"(",
"DVT",
")"
] | [
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT00840047 | 101:104:treatment,105:108:treatment,109:111:treatment,123:126:treatment, | Participants will have had, or are scheduled to have clinical imaging evaluations which may include FDG PET CT, or CT, or MRI within 4 weeks of entry | 1 | [
"Participants",
"will",
"have",
"had",
",",
"or",
"are",
"scheduled",
"to",
"have",
"clinical",
"imaging",
"evaluations",
"which",
"may",
"include",
"FDG",
"PET",
"CT",
",",
"or",
"CT",
",",
"or",
"MRI",
"within",
"4",
"weeks",
"of",
"entry"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02343042 | ,46:67:chronic_disease,140:150:treatment,154:179:treatment, | Any non-hematological toxicities (except for peripheral neuropathy as described in exclusion criterion #24) that patients experienced from treatments in previous clinical studies must have resolved to ≤ Grade 2 by Cycle 1 Day 1 | 1 | [
"Any",
"non-hematological",
"toxicities",
"(",
"except",
"for",
"peripheral",
"neuropathy",
"as",
"described",
"in",
"exclusion",
"criterion",
"#",
"24",
")",
"that",
"patients",
"experienced",
"from",
"treatments",
"in",
"previous",
"clinical",
"studies",
"must",
"have",
"resolved",
"to",
"≤",
"Grade",
"2",
"by",
"Cycle",
"1",
"Day",
"1"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01620216 | 7:41:chronic_disease | Known human immunodeficiency virus (HIV)-positive patient | 1 | [
"Known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"-positive",
"patient"
] | [
0,
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT00291525 | 1:35:chronic_disease | Left or right ventricular aneurysm | 1 | [
"Left",
"or",
"right",
"ventricular",
"aneurysm"
] | [
2,
2,
2,
2,
2
] |
NCT03038620 | 1:26:treatment | minor surgical procedures | 1 | [
"minor",
"surgical",
"procedures"
] | [
1,
1,
1
] |
NCT02171104 | 1:19:chronic_disease | Zellweger syndrome | 1 | [
"Zellweger",
"syndrome"
] | [
2,
2
] |
NCT01734512 | ,,12:27:treatment,79:87:treatment,111:122:treatment, | INR ≤1.5. (Anticoagulation is allowed if target INR ≤ 1.5 on a stable dose of warfarin or on a stable dose of LMW heparin for >2 weeks at time of randomization) | 1 | [
"INR",
"≤1.5",
".",
"(",
"Anticoagulation",
"is",
"allowed",
"if",
"target",
"INR",
"≤",
"1.5",
"on",
"a",
"stable",
"dose",
"of",
"warfarin",
"or",
"on",
"a",
"stable",
"dose",
"of",
"LMW",
"heparin",
"for",
">",
"2",
"weeks",
"at",
"time",
"of",
"randomization",
")"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02188121 | 1:14:chronic_disease,16:29:chronic_disease,39:45:treatment,50:67:treatment | renal failure, liver failure, or both statin and angiotension drug contraindications | 1 | [
"renal",
"failure",
",",
"liver",
"failure",
",",
"or",
"both",
"statin",
"and",
"angiotension",
"drug",
"contraindications"
] | [
2,
2,
0,
2,
2,
0,
0,
0,
1,
0,
1,
1,
0
] |
NCT02389517 | 23:31:allergy_name | History of allergy to mannitol | 1 | [
"History",
"of",
"allergy",
"to",
"mannitol"
] | [
0,
0,
0,
0,
4
] |
NCT02143726 | 21:42:chronic_disease | No known history of prolonged QT syndrome | 1 | [
"No",
"known",
"history",
"of",
"prolonged",
"QT",
"syndrome"
] | [
0,
0,
0,
0,
2,
2,
2
] |
NCT02838797 | 1:19:chronic_disease,,,, | active suicidality as measured by a most severe suicide ideation score of 4 or 5 on the Columbia-Suicide Severity Rating Scale (C-SSRS) | 1 | [
"active",
"suicidality",
"as",
"measured",
"by",
"a",
"most",
"severe",
"suicide",
"ideation",
"score",
"of",
"4",
"or",
"5",
"on",
"the",
"Columbia-Suicide",
"Severity",
"Rating",
"Scale",
"(",
"C-SSRS",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02291848 | ,,72:89:treatment | Pulse oximetry of >93% on room air in patients who previously received radiation therapy | 1 | [
"Pulse",
"oximetry",
"of",
">",
"93",
"%",
"on",
"room",
"air",
"in",
"patients",
"who",
"previously",
"received",
"radiation",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03138733 | 1:12:chronic_disease,, | tachycardia (heart rate > 90 bpm) | 1 | [
"tachycardia",
"(",
"heart",
"rate",
">",
"90",
"bpm",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01943851 | ,,,102:112:treatment | Female subjects must agree to use contraception until at least 7 months after the last dose of study medication | 1 | [
"Female",
"subjects",
"must",
"agree",
"to",
"use",
"contraception",
"until",
"at",
"least",
"7",
"months",
"after",
"the",
"last",
"dose",
"of",
"study",
"medication"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01943851 | 1:22:treatment, | Chemotherapy regimens with delayed toxicity within the last 4 weeks | 1 | [
"Chemotherapy",
"regimens",
"with",
"delayed",
"toxicity",
"within",
"the",
"last",
"4",
"weeks"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01810588 | 1:35:chronic_disease | Chronic myeloproliferative disease | 1 | [
"Chronic",
"myeloproliferative",
"disease"
] | [
2,
2,
2
] |
NCT02178566 | ,,,125:135:treatment | Women of childbearing potential must use a reliable method of contraception from screening until 1 month after end of study medication | 1 | [
"Women",
"of",
"childbearing",
"potential",
"must",
"use",
"a",
"reliable",
"method",
"of",
"contraception",
"from",
"screening",
"until",
"1",
"month",
"after",
"end",
"of",
"study",
"medication"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02988895 | 197:213:chronic_disease | other co-morbidities that in the investigator's opinion could require medical or surgical intervention to prevent or treat visual loss or media opacity that might result from that condition (i.e. severe cataracts) | 1 | [
"other",
"co-morbidities",
"that",
"in",
"the",
"investigator",
"'s",
"opinion",
"could",
"require",
"medical",
"or",
"surgical",
"intervention",
"to",
"prevent",
"or",
"treat",
"visual",
"loss",
"or",
"media",
"opacity",
"that",
"might",
"result",
"from",
"that",
"condition",
"(",
"i.e",
".",
"severe",
"cataracts",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT02301546 | 17:42:chronic_disease,50:63:chronic_disease,65:91:chronic_disease | Current or past major psychiatric illness (e.g., schizophrenia, bipolar affective disorder) | 1 | [
"Current",
"or",
"past",
"major",
"psychiatric",
"illness",
"(",
"e.g.",
",",
"schizophrenia",
",",
"bipolar",
"affective",
"disorder",
")"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
2,
0,
2,
2,
2,
0
] |
NCT02465060 | 23:34:chronic_disease | Patient must not have hypokalemia (value < institutional lower limit of normal) | 1 | [
"Patient",
"must",
"not",
"have",
"hypokalemia",
"(",
"value",
"<",
"institutional",
"lower",
"limit",
"of",
"normal",
")"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02796209 | 1:23:treatment | Wellbutrin (Bupropion) | 1 | [
"Wellbutrin",
"(",
"Bupropion",
")"
] | [
1,
1,
0,
0
] |
NCT01928576 | 1:8:treatment,12:28:treatment,41:60:treatment,,81:91:treatment,143:161:chronic_disease | Inhaled or topical steroids and adrenal replacement steroid doses > 10 mg daily prednisone equivalent, are permitted in the absence of active autoimmune disease | 1 | [
"Inhaled",
"or",
"topical",
"steroids",
"and",
"adrenal",
"replacement",
"steroid",
"doses",
">",
"10",
"mg",
"daily",
"prednisone",
"equivalent",
",",
"are",
"permitted",
"in",
"the",
"absence",
"of",
"active",
"autoimmune",
"disease"
] | [
1,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02135588 | ,40:52:treatment | At least 2 days from administration of chemotherapy | 1 | [
"At",
"least",
"2",
"days",
"from",
"administration",
"of",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02609685 | 64:91:cancer | Pathologically confirmed Bethesda V or VI thyroid nodules with papillary thyroid carcinoma | 1 | [
"Pathologically",
"confirmed",
"Bethesda",
"V",
"or",
"VI",
"thyroid",
"nodules",
"with",
"papillary",
"thyroid",
"carcinoma"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3
] |
NCT02682147 | 1:9:chronic_disease | diabetes | 1 | [
"diabetes"
] | [
2
] |
NCT02091141 | 19:42:chronic_disease | Participants with symptomatic bradycardia | 1 | [
"Participants",
"with",
"symptomatic",
"bradycardia"
] | [
0,
0,
2,
2
] |
NCT02654236 | 42:56:chronic_disease,65:81:chronic_disease,83:90:chronic_disease,106:124:chronic_disease,128:150:chronic_disease | Previous history of jaundice or signs of liver diseases such as spider angiomata, ascites, or history of esophageal varices or hepatic encephalopathy | 1 | [
"Previous",
"history",
"of",
"jaundice",
"or",
"signs",
"of",
"liver",
"diseases",
"such",
"as",
"spider",
"angiomata",
",",
"ascites",
",",
"or",
"history",
"of",
"esophageal",
"varices",
"or",
"hepatic",
"encephalopathy"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
2,
2,
0,
2,
2
] |
NCT01946074 | 74:86:cancer | Subject must have measurable disease per Response Evaluation Criteria In Solid Tumors (RECIST) version 1.1 | 1 | [
"Subject",
"must",
"have",
"measurable",
"disease",
"per",
"Response",
"Evaluation",
"Criteria",
"In",
"Solid",
"Tumors",
"(",
"RECIST",
")",
"version",
"1.1"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0
] |
NCT03051321 | 8:20:treatment | Active chemotherapy | 1 | [
"Active",
"chemotherapy"
] | [
0,
1
] |
NCT02324582 | 12:24:treatment, | received a live vaccine within 30 days | 1 | [
"received",
"a",
"live",
"vaccine",
"within",
"30",
"days"
] | [
0,
0,
1,
1,
0,
0,
0
] |
NCT02109627 | 16:28:treatment | The effects of ficlatuzumab on the developing human fetus are unknown | 1 | [
"The",
"effects",
"of",
"ficlatuzumab",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02046330 | 43:47:treatment | Presence of a condition requiring routine MRIs | 1 | [
"Presence",
"of",
"a",
"condition",
"requiring",
"routine",
"MRIs"
] | [
0,
0,
0,
0,
0,
0,
1
] |
NCT01737502 | 14:24:cancer | Other active malignancy | 1 | [
"Other",
"active",
"malignancy"
] | [
0,
0,
3
] |
NCT01128816 | 1:51:chronic_disease,59:67:chronic_disease,69:79:chronic_disease,83:95:chronic_disease, | American Heart Association Stage B-D Heart failure due to ischemic, idiopathic or hypertensive causes, present for at least 3 months | 1 | [
"American",
"Heart",
"Association",
"Stage",
"B-D",
"Heart",
"failure",
"due",
"to",
"ischemic",
",",
"idiopathic",
"or",
"hypertensive",
"causes",
",",
"present",
"for",
"at",
"least",
"3",
"months"
] | [
2,
2,
2,
2,
2,
2,
2,
0,
0,
2,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00293475 | 24:52:chronic_disease | Seropositivity for the human immunodeficiency virus | 1 | [
"Seropositivity",
"for",
"the",
"human",
"immunodeficiency",
"virus"
] | [
0,
0,
0,
2,
2,
2
] |
NCT01720836 | 4:25:treatment | No prior vaccine therapy | 1 | [
"No",
"prior",
"vaccine",
"therapy"
] | [
0,
1,
1,
1
] |
Subsets and Splits